Document And Entity Information
Document Information [Table]
Document Information [Line Items]
Document Type
Document Annual Report
Document Period End Date
Document Transition Report
Securities Act File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Voluntary Filers
Entity Well-known Seasoned Issuer
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Shell Company
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
Entity Public Float
Auditor Name
Auditor Firm ID
Auditor Location
Consolidated Balance Sheets
Statement [Table]
Statement [Line Items]
Statement
Assets [Abstract]
Assets
Assets, Current [Abstract]
Current assets:
Cash and Cash Equivalent
Cash and cash equivalents
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivable - trade, net of allowance for credit losses of $65 and $0 as of June 30, 2026 and June 30, 2025, respectively
Accounts receivable
Debt Securities, Available-for-Sale, Current
Investments in debt securities (adjusted cost $31,689 and $0 as of June 30, 2026 and June 30, 2025, respectively - see Note 6)
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable
Subscription receivable
Amortized cost, including accrued interest, of promissory note receivable classified as current.
Promissory Note Receivable, Including Accrued Interest, Current
Promissory note receivable and accrued interest
Promissory note receivable and accrued interest, current
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Assets, Current
Total Current Assets
Total current assets
Restricted Cash, Noncurrent
Restricted cash
Amortized cost including accrued interest, of promissory note receivable classified as noncurrent.
Promissory Note Receivable, Including Accrued Interest, Noncurrent
Promissory note receivable and accrued interest
Promissory note receivable and accrued interest, noncurrent
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Net finance lease ROU assets
Finance lease right-of-use assets, net of accumulated amortization
Finance lease ROU assets
Operating Lease, Right-of-Use Asset
Operating lease right-of-use asset, net of accumulated amortization
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
Net fixed assets
Fixed assets, net of accumulated depreciation
Intangible Asset, Excluding Goodwill, after Accumulated Amortization
Total net intangibles
Intangible assets, net of accumulated amortization
Prepaid Expense, Noncurrent
Prepaid expenses - noncurrent
Security Deposit
Security deposits
Assets
Total Assets
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity
Liabilities, Current [Abstract]
Current liabilities:
Accounts Payable, Current
Accounts payable
Accrued Liabilities, Current
Total accrued expenses
Accrued expenses
Finance Lease, Liability, Current
Finance lease obligations
Finance lease obligation - current portion
Operating Lease, Liability, Current
Less: current portion
Operating lease obligation - current portion
Secured Debt, Current
Equipment financing payable - current portion
Notes Payable, Current
Term promissory note
Contract with Customer, Liability, Current
Contract liabilities
Liabilities, Current
Total Current Liabilities
Operating Lease, Liability, Noncurrent
Operating lease obligation - net of current portion
Long-term portion of minimum lease obligation
Liabilities
Total Liabilities
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Equity:
Equity, Attributable to Parent [Abstract]
Stockholders' Equity
Preferred Stock, Value, Issued
Preferred Stock - $0.001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (see Note 16)
Common Stock, Value, Issued
Common Stock - $0.001 par value; 275,000,000 shares authorized; 55,698,561 and 19,349,201 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively
Additional Paid in Capital, Common Stock
Additional paid-in capital
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive loss
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Equity, Attributable to Parent
Total Stockholders' Equity
Liabilities and Equity
Total Liabilities and Stockholders' Equity
Accounts Receivable, Allowance for Credit Loss, Current
Allowance for credit losses
Debt Securities, Available-for-Sale, Amortized Cost, Current
Investments in debt securities, adjusted cost
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Preferred stock, par value
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Preferred stock, shares authorized
Preferred Stock, Shares Issued
Preferred stock, shares issued
Preferred stock, shares issued
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Preferred stock, shares outstanding
Common Stock, Par or Stated Value Per Share
Common stock, par value
Common Stock, Shares Authorized
Common stock, shares authorized
Common Stock, Shares, Issued
Common stock, shares issued
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Consolidated Statements of Operations
Revenue from Contract with Customer, Excluding Assessed Tax
Revenue
Operating Expenses [Abstract]
Operating expenses:
Research and Development Expense
Research and development
General and Administrative Expense
General and administrative
Intangible Asset, Excluding Goodwill, Indefinite-Lived, Impairment Loss
Impairments
Impairment of indefinite-lived intangible assets
Impairment of indefinite-lived intangible asset
Operating Expenses
Total operating expenses
Operating Income (Loss)
Operating loss
Nonoperating Income (Expense) [Abstract]
Other income (expense):
Investment Income, Interest
Interest income
Interest income
Interest Expense, Nonoperating
Interest expense
Nonoperating Income (Expense)
Total other income
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net loss before income taxes
Income Tax Expense (Benefit)
Income tax expense
Income tax expense
Net loss
Net loss
Net loss
Debt Securities, Available-for-Sale, Unrealized Gain (Loss)
Other comprehensive loss - unrealized loss on on debt securities
Net unrealized losses
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive loss
Earnings Per Share, Basic
Loss per common share - basic
Per share amount - total (basic)
Earnings Per Share, Diluted
Loss per common share - diluted
Per share amount - total (diluted)
Weighted Average Number of Shares Outstanding, Basic
Weighted-average common shares outstanding - basic
Weighted-average common shares outstanding (basic)
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average common shares outstanding - diluted
Weighted-average common shares outstanding (diluted)
Consolidated Statements of Stockholders' Equity
Equity Components [Axis]
Equity Component [Domain]
Common Stock [Member]
Common Stock
Additional Paid-in Capital [Member]
Additional Paid-in Capital
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Loss
Retained Earnings [Member]
Accumulated Deficit
Equity, Including Portion Attributable to Noncontrolling Interest
Equity, ending balance
Equity, beginning balance
Shares, Outstanding
Equity, ending balance (shares)
Equity, beginning balance (shares)
Stock Issued During Period, Value, New Issues
Common stock issued
Stock Issued During Period, Shares, New Issues
Common stock issued (shares)
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Exercised
Exercise of stock options (shares)
Shares exercised
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Vesting of RSUs
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Vesting of RSUs (shares)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Share-based compensation
Stock Issued During Period, Value, Purchase of Assets
AstrialBio Exclusive License Agreement shares issued
Stock Issued During Period, Shares, Purchase of Assets
AstrialBio Exclusive License Agreement shares issued (shares)
Adjustments to Additional Paid in Capital, Warrant Issued
Issuance of pre-funded warrants
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Unrealized loss on available-for-sale debt securities
Equity impact of the value of new stock issued during the period attributable to warrant inducements.
Stock Issued During Period, Value, Warrant Inducement
Warrant Inducement Transaction
Number of new stock issued during the period attributable to a warrant inducement.
Stock Issued During Period, Shares, Warrant Inducement
Warrant Inducement Transaction (in shares)
Consolidated Statements of Cash Flows
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile consolidated net loss to net cash used in operating activities:
Share-Based Payment Arrangement, Noncash Expense
Share-based compensation
Intangible Asset, Finite-Lived, Amortization Expense
Amortization of intangible assets
Amortization of intangible assets
Finance Lease, Right-of-Use Asset, Amortization
Amortization of finance lease right-of-use assets
Amortization of ROU assets
Operating Lease, Right-of-Use Asset, Periodic Reduction
Amortization of operating lease right-of-use assets
Depreciation
Depreciation of fixed assets
Increase (Decrease) in Accrued Interest Receivable, Net
Accrued interest receivable on promissory note receivable
Accretion (Amortization) of Discounts and Premiums, Investments
Amortization of premiums/(accretion of discounts) on debt securities, net
Net accretion of discounts on the debt securities purchased
Accounts Receivable, Credit Loss Expense (Reversal)
Provision for credit losses
Long-Lived Asset, Held and Used, Impairment Loss
Impairment of fixed assets
Intangible Asset, Excluding Goodwill, Impairment Loss
Impairment of intangible assets
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable
Accounts receivable - trade
Amount of increase (decrease) in prepaid expenses, and current assets classified as other.
Increase (Decrease) in Prepaid Expense and Other Current Assets
Prepaid expenses and other current assets
Amount of increase (decrease) in prepaid expenses, noncurrent.
Increase (Decrease) in Prepaid Expense, noncurrent
Prepaid expenses - noncurrent
Increase (Decrease) in Deposits Outstanding
Security deposit
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accrued Liabilities
Accrued expenses
Increase (Decrease) in Operating Lease Liability
Operating lease obligations
Increase (Decrease) in Contract with Customer, Liability
Contract liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operations
Net cash used in operating activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Cash flows from investing activities:
Payments to Acquire Debt Securities, Available-for-Sale
Purchases of debt securities
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale
Redemption of debt securities
Proceeds from Collection of Loans Receivable
Payment received for interest and principal on promissory note receivable
Payments to Acquire Property, Plant, and Equipment
Purchases of fixed assets
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash (used in) provided by investing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Cash flows from financing activities:
Proceeds from Issuance of Common Stock
Proceeds from sales of common stock
Proceeds from Issuance of Warrants
Proceeds from sales of pre-funded warrants
The cash inflow associated with the amount received the exercise of warrants for pre-funded warrants.
Proceeds from Exercise of Warrants for Pre-Funded Warrants
Proceeds from the exercise of warrants for pre-funded warrants
The cash inflow associated with the amount received the exercise of warrants for common stock.
Proceeds from Exercise of Warrants for Common Stock
Proceeds from the exercise of warrants for common stock
Payments of Stock Issuance Costs
Payments made for costs to acquire capital
Underwriting fees
Transaction costs
The cash inflow attributable from the warrant inducement transaction.
Proceeds from Warrant Inducement Transaction
Proceeds from Warrant Inducement Transaction
Proceeds from Stock Options Exercised
Proceeds from the exercise of stock options
Cash received from stock option exercises
The cash inflow from the sale of Common Stock in which the funds have not yet been delivered to the Company
Proceeds from Issuance of Common Stock, Subscription receivable
Subscription receivable
Repayments of Other Debt
Payment of equipment financing loan
Repayments of Notes Payable
Payment of term promissory note
Finance Lease, Principal Payments
Payment of finance lease obligation
Financing cash flows from finance lease obligations
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash, cash equivalents and restricted cash - end
Cash, cash equivalents and restricted cash - beginning
Total cash, cash equivalents and restricted cash
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
Schedule of non-cash activities:
The non-cash fair value of costs incurred from capital raising activities that are included in the balance of accrued expenses as of the balance sheet date.
Non Cash Activity Costs to Raise Capital in Accrued Expenses
Costs to raise capital included in accrued expenses
The fair value of reserves held in relation to the company's term promissory note that are included in the balance of prepaid expenses as of the balance sheet date.
Non Cash Activity Reserves for Term Promissory Note
Reserves related to term promissory note included in prepaid expenses
The non-cash effect of unrealized loss on available for sale debt securities.
Noncash Effect of Unrealized Loss on Available For Sale Debt Securities
Unrealized loss on available-for-sale debt securities
The non-cash fair value of unpaid fixed assets included in the accounts payable balance as of the balance sheet date.
Non Cash Activity Unpaid Fixed Assets in Accounts Payable
Unpaid fixed assets in accounts payable
The fair value of indefinite-lived intangible assets acquired in noncash investing or financing activities.
Non Cash Activity Intangible Asset Addition
Indefinite-lived intangible asset addition
The fair value of common stock shares issued as non-cash consideration in licensing agreement with AstralBio.
Non Cash Activity Shares Issued for License Fee
Shares issued to AstralBio for license fee
The fair value of credit provided by AstralBio as non-cash consideration.
Non Cash Activity Credit Provided by AstralBio
Credit provided by AstralBio
The fair value of common stock shares subscribed, but not issued.
Non Cash Activity Subscription Receivable
Subscription receivable
The non-cash fair value of costs incurred from capital raising activities that were settled as an offsetting charge to gross proceeds received.
Non Cash Activity Costs to Raise Capital
Costs to raise capital paid directly from gross proceeds
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activity
Cash paid during the year for interest
No definition available.
Nature of Business
Nature of Operations [Text Block]
Nature of Business
Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Basis of Presentation
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Financial Instruments and Fair Value Measurement
Fair Value Disclosures [Text Block]
Financial Instruments and Fair Value Measurements
No definition available.
Significant Transactions
The entire disclosure of significant transactions.
Disclosure of Significant Transactions [Text Block]
Significant Transactions
Investments in Debt Securities
Investment in Debt and Equity Securities and Other Trading Assets [Text Block]
Investments in Debt Securities
Promissory Note Receivable
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
Promissory Note Receivable
Finance Lease ROU Assets
The entire disclosure for lessee entity's finance lease right-of-use assets.
Finance Lease ROU Assets [Text Block]
Finance Lease ROU Assets
Operating Lease ROU Assets
The entire disclosure for lessee entity's operating lease right-of-use assets.
Operating Lease ROU Assets [Text Block]
Operating Lease ROU Assets
Fixed Assets
Property, Plant, and Equipment [Text Block]
Fixed Assets
Intangible Assets
Intangible Asset and Goodwill [Text Block]
Intangible Assets
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accrued Expenses
Debt
Debt Disclosure [Text Block]
Debt
Finance Lease Obligations
Lessee, Finance Leases [Text Block]
Finance Lease Obligations
Operating Lease Obligations
Lessee, Operating Leases [Text Block]
Operating Lease Obligations
Stockholders' Equity
Equity [Text Block]
Stockholders' Equity
Earnings (Loss) Per Common Share
Earnings Per Share [Text Block]
Earnings (Loss) Per Common Share
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
Share-Based Compensation
Income Taxes
Income Tax Disclosure [Text Block]
Income Taxes
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Employee 401(k) Plan
Defined Contribution Plan [Text Block]
Employee 401(k) Plan
Subsequent Events
Subsequent Events [Text Block]
Subsequent Events
Presentation of information pertaining to the company's summary of significant accounting policies.
Summary of Significant Accounting Policies [Table]
Summary of Significant Accounting Policies [Line Items]
Summary of Significant Accounting Policies
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Accounts Receivable [Policy Text Block]
Accounts Receivable
Receivable [Policy Text Block]
Subscription Receivable
Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition
Disclosure of accounting policy for contract assets.
Contract Assets [Policy Text Block]
Contract Assets
Disclosure of accounting policy for contract liabilities.
Contract Liabilities [Policy Text Block]
Contract Liabilities
Lessee, Leases [Policy Text Block]
Leases
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash, Cash Equivalents and Restricted Cash
Debt Securities, Available-for-Sale, Premium on Purchased Options [Policy Text Block]
Investments in Debt Securities
Research and Development Expense, Policy [Policy Text Block]
Research and Development
Disclosure of accounting policy for lessee right-of-use assets.
Leases, Right of Use Assets [Policy Text Block]
Finance Lease Right-of-Use Assets ("ROU") Assets
Property, Plant, and Equipment [Policy Text Block]
Fixed Assets
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible Assets
Share-Based Payment Arrangement [Policy Text Block]
Share-based Compensation
Income Tax, Policy [Policy Text Block]
Income Taxes
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentrations of Credit Risk
Segment Reporting, Policy [Policy Text Block]
Segment Reporting
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted and Recently Issued Accounting Pronouncements
Schedule of Cash and Cash Equivalents [Table Text Block]
Schedule of Total Cash, Cash Equivalents and Restricted Cash in the Condensed Consolidated Statements of Cash Flows
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
Schedule of fair value hierarchy
Presentation of information about significant transactions.
Disclosure of Significant Transactions [Table]
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Disclosure of Significant Transactions [Line Items]
Significant Transactions
Asset Acquisition [Table Text Block]
Schedule of asset acquisition
Debt Securities, Available-for-Sale [Table Text Block]
Schedule of components of available-for-sale debt securities
Investments Classified by Contractual Maturity Date [Table Text Block]
Schedule of fair value of available-for-sale debt securities, by contractual maturity
Tabular disclosure of finance lease right-of-use assets.
Finance Lease, Right of Use Assets [Table Text Block]
Schedule of Finance Lease ROU assets
Property, Plant, and Equipment [Table Text Block]
Schedule of gross carrying value and accumulated depreciation of fixed assets by category
Intangible Asset and Goodwill [Table Text Block]
Schedule of Gross Carrying Value and Accumulated Amortization of Intangible Assets
Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block]
Schedule of Intangible Assets Future Amortization Expense
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses
Lessee, Lease, Description [Table]
Long-Lived Asset, Class [Axis]
Long-Lived Asset, Class [Domain]
Information pertaining to assets operated under financing lease agreements.
Assets Operated Under Financing Lease [Member]
Finance Lease ROU Assets
Lessee, Lease, Description [Line Items]
Finance Lease Obligations
Operating Lease Obligations
Lease, Cost [Table Text Block]
Schedule of components of lease expense and supplemental balance sheet information related to the operating lease obligation
Information pertaining to assets operated under operating lease agreements.
Assets Operated Under Operating Lease [Member]
Operating lease
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Schedule of future minimum payments under the operating lease obligation
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Summary of the components of the earnings (loss) per common share calculation
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of shares issuable which could potentially dilute future earnings
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of Components of Share-Based Compensation Expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
Schedule of Stock Option Issuances During Period
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of Stock Option Activity
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
Schedule of Options Outstanding and Exercisable
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Black-Scholes Option Pricing Model Assumptions Used in Determining Fair Value of Stock Options Granted
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of Components of Income Tax Expense (Benefit)
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of Deferred Tax Assets and Deferred Tax Liabilities
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of Effective Income Tax Rate Reconciliation
Stock, Class of Stock [Table]
Sale of Stock [Axis]
Sale of Stock [Domain]
Represents information pertaining to a public offering.
Public Offering [Member]
Public Offering
Private Placement [Member]
Private placement
Class of Stock [Line Items]
Earnings (Loss) Per Common Share
Stockholders' Equity
Debt Securities, Current
Investments in debt securities
Sale of Stock, Consideration Received Per Transaction
Gross proceeds from sale of equity
Proceeds from Warrant Exercises
Proceeds from warrant exercises
Proceeds from the exercise of warrants
The aggregate amount of current assets denoted as cash and cash equivalents and investments in debt securities available-for-sale as of the balance sheet date.
Total cash and cash equivalents and investments in debt securities
Cash, cash equivalents, and investments in debt securities
Product and Service [Axis]
Product and Service [Domain]
Collaborative revenues generated typically include payment to the Company related to one or more of the following: non-refundable upfront license fees, development and commercial milestones, and partial or complete reimbursement of research and development costs.
Collaborative Revenues [Member]
Collaborative Revenues
Contract with Customer, Receivable, Allowance for Credit Loss
Contract with Customer, Receivable, Allowance for Credit Loss
Contract with Customer, Asset, after Allowance for Credit Loss, Current
Contract assets
Contract with Customer, Liability, Revenue Recognized
Revenue recognized included in contract liabilities
Restricted Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Domain]
Represents the information pertaining to letter of credit for sandiego lease.
Letter Of Credit - San Diego Lease [Member]
Collateral held for letter of credit - San Diego lease
Information related to the Company purchasing card.
Company Purchasing Card [Member]
Collateral held for Company purchasing card
The percentage of collateral required to be held by the reporting entity.
Percentage Of Collateral Required
Additional collateral held by bank (percentage of credit issued)
Debt Securities, Available-for-Sale, Allowance for Credit Loss
Allowance for Credit Loss, AFS Debt Securities
Location, Statement of Income, Balance [Axis]
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum [Member]
Minimum
Maximum [Member]
Maximum
Property, Plant, and Equipment, Useful Life
Fixed assets, useful life
Impairment of Long-Lived Assets to be Disposed of
Fixed asset impairment charge
Intangible Asset, Finite-Lived, Useful Life
Intangible asset, useful life
Share-Based Payment Arrangement, Valuation Technique [Extensible Enumeration]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend yield
Unrecognized Tax Benefits
Liability for uncertain tax positions
Concentration Risk [Table]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Domain]
Revenue Benchmark [Member]
Revenues
Concentration Risk Type [Axis]
Concentration Risk Type [Domain]
Customer Concentration Risk [Member]
Customer concentration risk
Cash and Cash Equivalents [Axis]
Certificates of Deposit [Member]
Certificates of deposits
Concentration Risk [Line Items]
Summary of Significant Accounting Policies
Cash, Uninsured Amount
Cash deposits held in excess of FDIC insured amount
Represents the number of significant customers who contribute to the Company's operating revenues.
Number of Significant Customers Contributing to Operating Revenues
Number of significant customers
Number of Reportable Segments
Number of reportable segments
Number of Operating Segments
Number of operating segments
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 1 [Member]
Level 1
Fair Value, Inputs, Level 2 [Member]
Level 2
Financial Instrument [Axis]
Financial Instruments [Domain]
US Government Agencies Debt Securities [Member]
U.S. Government agency securities
Corporate Debt Securities [Member]
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Instruments and Fair Value Measurements
Assets, Fair Value Disclosure [Abstract]
Assets:
Cash and Cash Equivalents, Fair Value Disclosure
Cash equivalents
Investments, Fair Value Disclosure
Investments
Assets, Fair Value Disclosure
Total financial assets
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Information pertaining to the exclusive licensing agreement with AstralBio for Myostatin.
Exclusive License Agreement with AstralBio for Myostatin [Member]
Myostatin License Agreement
Information pertaining to the exclusive licensing agreement with AstralBio for Activin E.
Exclusive License Agreement with AstralBio for Activin E [Member]
Activin E License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Significant Transactions
Payments for Other Fees
Payment of upfront licensing fee
Sale of Stock, Number of Shares Issued in Transaction
Number of common stock shares issued
Number of shares issued
Potential amount of contingent payments payable by the company upon achievement of specified milestones related to the Company's licensing agreement with AstralBio.
Potential contingent payments related to licensing agreement
Aggregate potential milestone payments payable in licensing agreement
The ceiling on stock ownership percentage in connection with milestone payments from licensing agreement settled in the form of the Company's common stock
Ceiling on stock ownership percentage
Equity ownership (ceiling)
Intangible Asset, Finite-Lived [Table]
Scenario [Axis]
Scenario [Domain]
Represents information pertaining to an asset purchase agreement (the "PD-1 Purchase Agreement") with Otsuka Pharmaceutical Co., Ltd. ("Otsuka").
Otsuka, PD1 Purchase Agreement [Member]
PD-1 Purchase Agreement
Intangible Asset, Finite-Lived, Class [Axis]
Intangible Asset, Finite-Lived, Class [Domain]
Intellectual Property [Member]
Intellectual Property
Intangible Asset, Finite-Lived [Line Items]
Intangible Assets
Significant Transactions
Proceeds from Sale of Intangible Assets
Proceeds from sale of intellectual property
Potential amount of contingent payments receivable by the company upon achievement of specified milestones following commercialization.
Potential contingent payments to be received related to sale of intellectual property
Information pertaining to a purchase and sale agreement with College Station.
College Station Purchase and Sale Agreement [Member]
Purchase and Sale Agreement
Information pertaining to a credit agreement with Woodforest.
Woodforest Credit Agreement [Member]
Credit Agreement
Represents the information pertaining to the Warrant Agreement with Bryan Capital.
Warrant Agreement With Bryan Capital [Member]
Warrant Agreement
Lease Agreements [Member]
Ground lease agreement
Credit Facility [Axis]
Credit Facility [Domain]
Secured Debt [Member]
Equipment Financing
Secured term Loan
Asset Acquisition, Consideration Transferred
Total purchase price
Payments to Acquire Productive Assets
Cash payments to acquire productive assets
Debt Instrument, Face Amount
Principal amount borrowed
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Number of shares which may be issued upon conversion of warrants
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price per share of warrants
Warrants, exercise price
Number of securities into which the class of warrant or right may be converted representing the final payment of the sublease.
Class of Warrant or Right, Number of Securities Called by Warrants Representing Final Payment of Sublease
Number of shares which may be issued upon exercise of warrants reflecting the final payment of rent due under sublease
Value of warrants outstanding, presenting the final payment of final rent due under a sublease.
Value of Warrants Outstanding Representing Final Payment of Rent Due Under Sublease
Amount representing final rent under sublease
Information pertaining to a collaboration, option and license agreement with RubrYc.
RubrYc, Collaboration, Option and License Agreement [Member]
Collaboration, Option and License Agreement
Information pertaining to a stock purchase agreement with RubrYc.
RubrYc, Stock Purchase Agreement [Member]
Stock Purchase Agreement
Asset Class [Axis]
Asset Class [Domain]
Preferred Stock [Member]
Preferred stock
Finite-Lived Intangible Assets [Member]
Intangible assets
Represents information pertaining to prepaid expenses.
Prepaid Expenses [Member]
Prepaid expenses
Representing information pertaining to fixed assets.
Fixed Assets [Member]
Fixed assets
Term of agreement
Collaboration and license agreement, agreement term
Term of agreement
Number of equity shares purchased in an asset acquisition transaction.
Equity Securities, Number of Shares Acquired
Number of shares acquired
Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in as asset acquisition transaction.
Asset Acquisition, Consideration Transferred, Equity Interest, Shares Issued, Number of Shares
Number of shares issued in asset acquisition
Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable
Value of equity interest issued as consideration
Fair value amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.
Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Fair Value
Fair value of shares issued
Maximum amount of liability from contingent consideration in asset acquisition available upon achievement of specified milestones.
Asset Acquisition, Maximum Contingent Consideration
Potential additional payments
Amount of consideration transferred in advance of closing of an asset acquisition transaction.
Asset Acquisition, Advance Payment
Advance payment
Asset Acquisition, Consideration Transferred, Transaction Cost
Transaction costs
Other than Temporary Impairment Losses, Investments
Impairment of investment
Impairment of current prepaid expenses.
Impairment Of Prepaid Expenses, Current
Impairment of current prepaid expense
Impairment of non-current prepaid expenses.
Impairment Of Prepaid Expenses, Non Current
Impairment of noncurrent prepaid expense
Represents the number of equipment leases.
Number of Equipment Leases
Number of equipment leases assumed in asset acquisition
Finance Lease, Liability
Finance lease obligations
Financing lease liabilities assumed in acquisition
Number of milestones achieved during the period under terms of an asset purchase agreement.
Asset Acquisition, Contingent Consideration, Number of Milestones Achieved
Number of milestones achieved
Asset Acquisition, Contingent Consideration, Liability
Liability for contingent consideration
Debt Securities, Available-for-Sale [Table]
Debt Securities, Available-for-Sale [Line Items]
Investments in Debt Securities
Investment Interest Rate
Interest rate
Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]
Components of investments in debt securities
Debt Securities, Available-for-Sale, Amortized Cost
Adjusted cost
Debt Securities, Available-for-Sale
Fair value
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair value of available-for-sale debt securities, by contractual maturity
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
2027
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in the second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year Two
2028
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in the third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year Three
2029
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
Total
Accounts and Financing Receivables [Table]
Receivable Type [Axis]
Receivable [Domain]
Notes Receivable [Member]
Promissory Note
Represents information pertaining to the first one year extension of a promissory note receivable.
Promissory Note Receivable, First One Year Extension [Member]
First 1 year extension
Represents information pertaining to the second one year extension of a promissory note receivable.
Promissory Note Receivable, Second One Year Extension [Member]
Second 1 year extension
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory Note Receivable
Financing Receivable, before Allowance for Credit Loss
Principal amount
Debt Instrument, Term
Term of debt agreement
Number of extensions available to a debt instrument.
Debt Instrument, Number of Extensions
Number of extensions
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Debt Instrument, Term of Each Extension
Term of each extension
Percentage of fixed rate of interest on notes.
Loans Receivable, Fixed Rates of Interest
Fixed interest rate
Payments received for interest owed to the Company for interest accrued on notes issued.
Notes receivable, payments for interest
Interest payments received
Payments received for notes issued, amounts applied directly to principal balance.
Notes receivable, payments on principal balance
Principal payments received
Equipment [Member]
Equipment
Asset Acquisition [Axis]
Asset Acquisition [Domain]
Represents information pertaining to RubrYc Therapeutics, Inc.
RubrYc Therapeutics Inc [Member]
RubrYc Therapeutics
Represents the number of finance lease right of use assets returned.
Number of Finance Lease Right of Use Assets Returned
Number of finance lease ROU assets returned
Represents the number of finance lease right of use assets purchased.
Number of Finance Lease Right of Use Assets Purchased
Number of finance lease ROU assets purchased
Finance Lease, Right-of-Use Asset, before Accumulated Amortization
ROU - Equipment
Finance Lease, Right-of-Use Asset, Accumulated Amortization
Accumulated amortization
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table]
Geographical [Axis]
Geographical [Domain]
Represents the information pertaining to San Diego.
San Diego [Member]
San Diego, California
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]
Operating Lease ROU Asset
Area of Real Estate Property
Area of leased facility
Property, Plant, and Equipment [Table]
Building and Building Improvements [Member]
Building and improvements
Machinery and Equipment [Member]
Machinery and equipment
Office Equipment [Member]
Office equipment and software
Asset under Construction [Member]
Construction in progress
Property, Plant, and Equipment [Line Items]
Fixed Assets
Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
Gross fixed assets
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Accumulated depreciation
Depreciation, Excluding Lessor Asset under Operating Lease
Depreciation expense - fixed assets
Indefinite-Lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure
Fair value of indefinite-lived intangible assets
Intangible Asset, Indefinite-Lived, Class [Axis]
Intangible Asset, Indefinite-Lived, Class [Domain]
Indefinite-lived intellectual property.
Indefinite Lived Intellectual Property [Member]
Intellectual property
Licensing Agreements [Member]
Licenses
Intangible Asset, Finite-Lived [Roll Forward]
Definite-lived intangible assets
Intangible Asset, Finite-Lived, before Accumulated Amortization
Gross carrying value
Intangible Asset, Finite-Lived, Accumulated Amortization
Accumulated amortization
Intangible Asset, Finite-Lived, after Accumulated Amortization
Total definite lived intangible assets
Intangible Asset, Indefinite-Lived [Roll Forward]
Indefinite-lived intangible assets
Intangible Asset, Excluding Goodwill, Indefinite-Lived
Indefinite lived
Intangible Asset, Excluding Goodwill, after Accumulated Amortization [Abstract]
Total net intangibles
Intangible Asset, Indefinite-Lived, Acquired
Indefinite-lived assets acquired
Intangible Asset, Finite-Lived, Acquired
Finite-lived assets acquired
Intangible Asset, Finite-Lived, Remaining Amortization Period
Average remaining amortization period
Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity [Abstract]
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One
2027
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two
2028
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three
2029
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four
2030
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Five
2031
Intangible Asset, Finite-Lived, Estimated Amortization Expense, after Year Five
Thereafter
Amounts payable for research and development milestones.
Research and Development Milestone Liability, Current
R&D milestone
Employee-related Liabilities, Current
Personnel related costs
Costs to raise capital, classified as current.
Costs to Raise Capital, Current
Costs to raise capital
Accrued Professional Fees, Current
Professional fees
Other Accrued Liabilities, Current
Other accrued expenses
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Debt Instrument [Line Items]
Debt
Debt Instrument, Interest Rate, Stated Percentage
Imputed interest rate
Debt Instrument, Frequency of Periodic Payment
Frequency of periodic payments
Debt Instrument, Periodic Payment
Periodic payment amount
Interest Expense, Debt
Interest expense on debt
Secured Debt
Balance outstanding
Long-Term Debt, Type [Axis]
Long-Term Debt, Type [Domain]
Line of Credit [Member]
Credit and Security Agreement
Represents information pertaining to the 2024 Term Note.
Term Loan, 2024 [Member]
2024 Term Note
Represents information pertaining to the credit and security agreement if there is an event of default.
Credit and Security Agreement Event Of Default [Member]
Event of Default
Debt Instrument, Description of Variable Rate Basis
Description of Variable Rate Basis
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]
Debt Instrument, Basis Spread on Variable Rate
Spread on base interest rate
Proceeds from Notes Payable
Proceeds from issuance of term note
Payments of Debt Issuance Costs
Origination fee
The cash outflow for appraisal costs associated with origination of a term loan.
Payments of Term Loan Appraisal Costs
Appraisal costs
The cash outflow for bank wire fees associated with origination of a term loan.
Payments of Term Loan Bank Wire Fees
Bank wire fees
The fee, expressed as a percentage of the total principal amount being prepaid, when a prepayment on the loan balance occurs on, after 12 months, but prior-to 24 months, from the loan origination date.
Prepayment Fee, Percentage of Principal Amount Repaid When Prepayment Occurs After One Year, But Prior-to Two Years, From Issuance
Fee percentage applied to principal prepayments (12 months or less from origination)
The fee, expressed as a percentage of the total principal amount being prepaid, when a prepayment on the loan balance occurs on, or prior-to, 12 months from the loan origination date.
Prepayment Fee, Percentage of Principal Amount Repaid When Prepayment Occurs Prior to One Year From Issuance
Fee percentage applied to principal prepayments (12-24 months from origination)
Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid
Balloon payment payable (January 2026)
Amount of interest included in the balloon payment associated with term loan under the Credit and Security Agreement.
Interest costs included in balloon payment liability
Interest included in balloon payment payable (January 2026)
Long-Term Line of Credit
Balance outstanding
Amount of monthly payments required under terms of a finance lease.
Finance Lease, Monthly Payment Amount
Monthly lease payments
Lease, Cost [Abstract]
Finance lease cost:
Operating lease cost:
Finance Lease, Interest Expense
Interest on lease liabilities
Lease, Cost
Total lease cost
Cash Flow, Financing Activities, Lessee [Abstract]
Other information:
Finance Lease, Weighted Average Remaining Lease Term
Weighted average remaining lease term - finance lease
Finance Lease, Weighted Average Discount Rate, Percent
Weighted average discount rate - finance lease obligation
Guarantor Obligations, Nature [Axis]
Guarantor Obligations, Nature [Domain]
Financial Standby Letter of Credit [Member]
Letter of Credit
Lessee, Operating Lease, Term of Contract
Term of lease
Variable Lease, Payment
Monthly lease payments
Lessee Operating Lease, Annual percentage increase in base rent
Lessee Operating Lease, Annual percentage increase in base rent
Annual increase in monthly rent
Allowance amount specified in terms of the lease allowed by the landlord for tenant improvements.
Tenant Improvement Allowance
Tenant improvement allowance
Guarantor Obligations, Maximum Exposure, Undiscounted
Irrevocable letter of credit
Operating Lease, Cost
Operating lease cost
Cash Flow, Operating Activities, Lessee [Abstract]
Other information:
Operating Lease, Payments
Operating cash flows from operating lease
Operating Lease, Payments, Use
Operating cash flows from operating lease obligation
Operating Lease, Weighted Average Remaining Lease Term
Weighted average remaining lease term - operating leases
Operating Lease, Weighted Average Discount Rate, Percent
Weighted average discount rate - operating lease obligations
Lease Contractual Term [Axis]
Lease Contractual Term [Domain]
Information pertaining to principal portion of the obligation.
Principal [Member]
Principal
Information pertaining to interest portion of the obligation.
Interest [Member]
Imputed Interest
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Future minimum payments under the operating lease obligation
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Lessee, Operating Lease, Liability, to be Paid
Total minimum lease payments
Class of Stock [Axis]
Class of Stock [Domain]
Convertible Preferred Stock [Member]
Series 2022 Preferred Stock
Preferred Stock, Convertible, Conversion Ratio
Preferred stock, conversion ratio
Convertible Preferred Stock, Shares Issued upon Conversion
Common shares issued upon conversion of preferred stock
Represents information relating to the 2022 Equity Offering.
Equity Offering, 2022 [Member]
2022 Offering
Represents information relating to the underwriters option related to the 2022 Equity Offering.
Equity Offering, 2022, Underwriter Option [Member]
2022 Offering, Underwriter Option
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Represents the information pertaining to 2022 Pre-Funded Warrants.
Pre-Funded Warrants, 2022 [Member]
2022 Pre-Funded Warrants
Represents information pertaining to Series A and Series B warrants.
Series A and B Warrants [Member]
2022 Warrants
Represents the member information pertaining to Series A Common Stock purchase warrants.
Series A Common Stock Purchase Warrants [Member]
Series A Warrants
Represents information pertaining to series B warrants.
Series B Warrants [Member]
Series B Warrants
Represents the information pertaining to representative warrants.
Representative Warrants [Member]
Representative Warrants
Underwriting fee paid to agent for the sale of stock, expressed as a percentage of gross proceeds received.
Underwriting Discount Fee Percentage
Underwriting discount percentage
Threshold number of days following the close of an at-the-market equity offering for the underwriters of the offering to exercise their option to purchase additional shares/warrants pursuant to an Underwriting Agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Underwriters purchase option period
Underwriters purchase option period
Number of common shares which may be issued under terms of the underwriter option agreement.
Underwriter Option, Number of Common Shares Which May Be Purchased
Underwriter option, number of additional common shares
Number of common shares which may be issued upon exercise of warrants under terms of the underwriter option agreement.
Underwriter Option, Number of Common Shares Which May Be Purchased Upon Exercise of Warrants
Underwriter option, additional warrants to purchase common shares
The number of warrants or rights issued.
Class of Warrant or Right, Issued
Warrants issued
The effective ownership of the outstanding shares of the Company's common stock immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed.
Ownership threshold percentage
Warrant exercise, common stock ownership limitation
The effective ownership of the outstanding shares of the Company's common stock, with written notice given by the holder to the Company, immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed.
Ownership threshold percentage election of holder
Warrant exercise, common stock ownership limitation (at the election of the holder)
Minimum days of prior written notice needed to satisfy the holder's election to exercise warrants that give the holder, together with affiliates, a beneficial ownership in the Company's common stock of not more than 9.99%.
Warrant exercises ownership limitation term of written notice
Warrant holder's election, period of written notice
The maximum amount of additional shares available for purchase by underwriters through the issuance of warrants, expressed as a percentage of the aggregate number of shares of common stock and pre-funded warrants currently included in equity offerings.
Percentage of total common shares in offering, warrants available for underwriters
Additional shares for purchase, percentage of aggregate shares in offerings
Sale of Stock, Consideration Received on Transaction
Net proceeds from sale of equity
Warrants and Rights Outstanding, Term
Warrants, exercisable term
Shares of stock issued as a result of the exercise of warrants.
Warrants, Exercises in Period for Common Stock
Warrants exercised for common stock
Information pertaining to the 2023 Securities Purchase Agreement.
Securities Purchase Agreement, 2023 [Member]
2023 Securities Purchase Agreement
Represents the information pertaining to 2023 Pre-Funded Warrants.
Pre-Funded Warrants, 2023 [Member]
2023 Pre-Funded Warrants
Represents the member information pertaining to Series C and D Warrants.
Series C and D Warrants [Member]
Common Warrants
Represents the member information pertaining to Series C Warrants.
Series C Warrants [Member]
Series C Common Warrants
Represents the member information pertaining to Series D Warrants.
Series D Warrants [Member]
Series D Common Warrants
Per share amount for each unit which includes 1 common stock share and 1 common stock warrant.
Sale of Stock, Price Per Unit, Common Share and Common Share Warrants
Combined price of each share of Common Stock and the accompanying Common Warrants
Per share amount for each unit which includes 1 pre-funded warrant and 1 common share warrant.
Sale of Stock, Price Per Unit, Pre-Funded Warrants and Common Share Warrants
Combined purchase price of each Pre-Funded Warrant and the accompanying Common Warrants
The cash outflow for cost incurred directly with the issuance of an equity security for the reimbursement of legal expenses incurred by the sales agent.
Stock issuance costs, legal expense reimbursement
Reimbursement for legal expenses
The cash outflow for cost incurred for a non-accountable expense allowance granted to the sales agent.
Non accountable expense allowance granted to sales agent
Non-accountable expense allowance
Amount accrued for stock issuance costs incurred and payable to the sales agent.
Accrued stock issuance costs
Represents information pertaining to the 2024 Securities Purchase Agreement.
Securities Purchase Agreement, 2024 [Member]
2024 Securities Purchase Agreement
Represents the information pertaining to 2024 Pre-Funded Warrants.
Pre-Funded Warrants, 2024 [Member]
2024 Pre-Funded Warrants
Represents the member information pertaining to Series E Warrants.
Series E Warrants [Member]
Series E Warrants
Maximum number of days following the filing date of the 2024 Securities Purchase Agreement the Company has agreed to prepare and file a registration statement with the Securities and Exchange Commission registering the resale of the shares of Common Stock issued to the Securities Purchasers in the Private Placement and the shares underlying the 2024 Pre-Funded Warrants and the Series E Warrants.
Days to file registration statement
In the event of a "full review" by the SEC, the maximum number of days following the filing date of the 2024 Securities Purchase Agreement the Company has agreed to prepare and file a registration statement with the Securities and Exchange Commission registering the resale of the shares of Common Stock issued to the Securities Purchasers in the Private Placement and the shares underlying the 2024 Pre-Funded Warrants and the Series E Warrants.
Days to file registration statement SEC Review
Duration of the 2024 Securities Purchase Agreement.
Duration of securities purchasing agreement
Registration statement effective period
Number of days in which the Company may suspend the 2024 Securities Purchase Agreement inside the one year period without being in breach.
Days to suspend securities purchasing agreement
Suspension period
Reduced placement agent fees for certain investors paid in cash, represented as a percentage of aggregate gross proceeds.
Reduced Placement Agent Fees Paid As A Percentage Of Aggregate Gross Proceeds
Reduced placement agent fee percentage
Represents information pertaining to the ATM agreement.
At the Market Agreement [Member]
ATM Agreement
The aggregate amount of proceeds from sales of common stock authorized through the medium of an investment bank, pursuant to an equity offering agreement.
Aggregate offering price in stock sales agreement
Aggregate offering price
Represents information pertaining to the 2025 Securities Purchase Agreement.
Securities Purchase Agreement, 2025 [Member]
2025 Securities Purchase Agreement
Sale of Stock, Price Per Share
Price per share
Information pertaining to the AstralBio Myostatin License agreement.
AstralBio Myostatin License Agreement [Member]
AstralBio Myostatin License Agreement
Class of Warrant or Right [Table]
Represents information pertaining to inducement of existing warrants.
Inducement of Existing Warrants [Member]
Inducement of Existing Warrants
Represents information pertaining to existing warrants.
Existing Warrants [Member]
Existing warrants
Represents information pertaining to inducement warrants.
Inducement Warrants [Member]
Inducement warrants
Represents information pertaining to inducement Series A warrants.
Inducement Warrants, Series A [Member]
Series A Warrants
Represents information pertaining to inducement Series C and Series D warrants.
Inducement Warrants, Series C and Series D [Member]
Series C and Series D Warrants
Represents information pertaining to inducement Series C warrants.
Inducement Warrants, Series C [Member]
Series C Warrants
Represents information pertaining to inducement Series D warrants.
Inducement Warrants, Series D [Member]
Series D Warrants
Represents information pertaining to inducement Series E warrants.
Inducement Warrants, Series E [Member]
Series E Warrants
Class of Warrant or Right [Line Items]
Stockholders' Equity
Reduced exercise price per share or per unit of warrants or rights outstanding.
Class of Warrant or Right, Reduced Exercise Price of Warrants or Rights
Reduced warrant exercise price
The percentage of common stock issuable in relation to each warrant upon exercise.
Inducement warrants conversion percentage to common stock
Inducement warrants conversion percentage to common shares
Per share or per unit amount of consideration received for the issuance of inducement warrants.
Consideration per share of inducement warrants
Consideration per share
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Represents information pertaining to the 2025 Leerink Underwriting Agreement.
Leerink Underwriting Agreement, 2025 [Member]
2025 Underwriting Agreement
Represents the information pertaining to the additional round of warrants ("Series G Warrants") and ("Series H Warrants") issued to purchase common stock.
Series G and Series H Warrants [Member]
Series G and Series H Warrants
Represents the information pertaining to the additional round of warrants ("Series G Warrants") issued to purchase common stock.
Series G Warrants [Member]
Series G Warrants
Represents the information pertaining to the additional round of warrants ("Series H Warrants") issued to purchase common stock.
Series H Warrants [Member]
Series H Warrants
Represents the information pertaining to 2025 Pre-Funded Warrants.
Pre-Funded Warrants, 2025 [Member]
2025 Pre-Funded Warrants
Represents the information pertaining to the additional round of warrants ("Series G Warrants") issued to purchase common stock combined with Pre-funded warrants.
Pre-funded Series G Warrants [Member]
Pre-funded Series G Warrants
Represents the information pertaining to the additional round of warrants ("Series H Warrants") issued to purchase common stock combined with Pre-funded warrants.
Pre-funded Series H Warrants [Member]
Pre-funded Series H Warrants
Represents the information pertaining to the additional round of warrants ("Series G Warrants") issued to purchase common stock combined with Pre-funded warrants.
Pre Funded Warrants and Series G Warrants [Member]
Pre Funded Warrants and Series G Warrants
Location, Statement of Financial Position, Balance [Axis]
Subsidiary, Sale of Stock [Line Items]
Stockholders' Equity
The amount of additional gross proceeds available upon exercise of warrants.
Additional Gross Proceeds Available Upon Exercise of Warrants
Additional gross proceeds available upon exercise of warrants
Pre-funded warrants issued as a result of the exercise of warrants.
Warrants, Exercises in Period for Pre-funded Warrants
Warrants exercised for pre-funded warrants
Period during which the Company is obligated to pay placement agent fees related to cash exercises of warrants, measured from the closing of the related transaction, as specified in the underwriting agreement.
Underwriting Arrangement, Warrant Exercise Related Fee, Term
All cash exercises of warrants, period
Number of business days following the each calendar quarter within which placement agent fee is required to pay.
Placement Agent Fee, Quarterly Payment Due Period
Placement agent fee, quarterly payment due period
Deferred Offering Costs
Transaction fees
Represents information pertaining to the 2026 Securities Purchase Agreement.
Securities Purchase Agreement, 2026 [Member]
2026 Securities Purchase Agreement
Represents the information pertaining to 2026 Pre-Funded Warrants.
Pre-Funded Warrants, 2026 [Member]
2026 Pre-Funded Warrants
Per share amount received by subsidiary or equity investee for each warrant issued or sold in the stock transaction.
Sale of Stock, Price Per Warrant
Price per warrant
Represents information pertaining to the 2026 ATM agreement.
At the Market Agreement, 2026 [Member]
2026 ATM Agreement
The cash outflow for costs incurred with the filing of the annual report.
Legal Fees for Filing of Annual Report
Fees related to 10-K filing
The cash outflow for costs incurred with the filing of a quarterly report.
Legal Fees for Filing of Quarterly Report
Fees related to 10-Q filing
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Restricted Stock Units (RSUs) [Member]
Restricted stock units
RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation
Stockholders' Equity
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised
Exercised (in dollars per share)
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
Exercise price - Lower range
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
Exercise price - Upper range
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Shares vested
Counterparty Name [Axis]
Counterparty Name [Domain]
Represents the information pertaining to Bryan Capital.
Bryan Capital [Member]
Bryan Capital
Information pertaining to Woodford National Bank.
Woodforest National Bank [Member]
Woodforest
Information pertaining to Lynx1 Master Fund LP.
Lynx1 Master Fund LP [Member]
Lynx1
Notes Payable to Banks [Member]
Term Promissory Note
Represents the information pertaining to Pre Funded Warrants.
Pre Funded Warrants [Member]
Pre-Funded Warrants
Share price of common stock on the settlement date underlying the warrants issued to purchase common stock.
Value of common stock per share at settlement date
Fair value of common stock per share at settlement date
Repayments of Long-Term Lines of Credit
Proceeds from sale of property paid to Woodforest to settle debt
Escrow Deposit Disbursements Related to Property Acquisition
Payment from restricted cash to pay down debt
Number of warrants exercised.
Class of Warrant or Right, Number Warrants Exercised
Number of warrants exercised
The number of shares issued in connection with the exercise of warrants.
Common stock, shares issued from exercise of warrants
Common stock issued upon exercise of warrants
Common Stock, Capital Shares Reserved for Future Issuance
Shares reserved for issuance of grants
Common stock, shares available for future issuance
Class of Warrant or Right, Outstanding
Number of warrants outstanding
Net Income (Loss) Attributable to Parent [Abstract]
Basic and diluted numerator:
Net Income (Loss) Available to Common Stockholders, Basic
Net loss - total, basic
Net Income (Loss) Available to Common Stockholders, Diluted
Net loss - total, diluted
Earnings Per Share, Basic [Abstract]
Basic and diluted denominator:
Weighted Average Number of Shares Issued, Basic
Weighted-average common shares outstanding
Weighted Average Number of Shares, Contingently Issuable
Weighted-average pre-funded warrants assumed exercised
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Warrant [Member]
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Shares excluded from the calculation of diluted loss per share
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Compensation
Share-Based Payment Arrangement, Expense
Share-based compensation expense
Plan Name [Axis]
Plan Name [Domain]
Information pertaining to the Company's 2023 Omnibus Equity Incentive Plan.
Omnibus Equity Incentive Plan 2023 [Member]
2023 Omnibus Equity Incentive Plan
2023 Plan
Information pertaining to the Company's 2020 Omnibus Equity Incentive Plan.
Omnibus Equity Incentive Plan 2020 [Member]
2020 Omnibus Equity Incentive Plan
Title and Position [Axis]
Title and Position [Domain]
Person serving on board of directors but not classified as an employee.
Non-Employee Director [Member]
Non-employee director
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Number of awards authorized under plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
Annual increase in shares available under plan
Maximum share-based compensation that may be paid to non-employee directors in a given calendar year.
Non-Employee Compensation Maximum Annual Distribution
Maximum annual awards paid to non-employee directors
Maximum share-based compensation that may be paid to non-employee directors in a given calendar year with an initial appointment of a board member occurs.
Non-Employee Director Compensation Maximum Annual Distribution Initial Appointment
Maximum annual awards paid to non-employee directors (newly appointed board member)
Maximum share-based compensation that may be paid to non-employee directors in a given calendar year when an appointment of a new chairman of the Company's board occurs.
Non-Employee Director Compensation Maximum Annual Distribution Initial Chair Appointment
Maximum annual awards paid to non-employee directors (newly appointed board chairman)
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Option term
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Increase in shares available for future grant
Aggregate number of common shares that have been issued under the plan.
Aggregate Number of Shares Issued Under the Plan
Aggregate number of shares issued under the plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Remaining shares available for future issuance
Aggregate number of common shares that are no longer available for future issuance.
Shares no longer available for future issuance
Shares no longer available for future issuance
Information pertaining to the Stock Option Issuance - Employment Inducement Grant, as part of the Company's 2023 Omnibus Equity Incentive Plan.
Stock Option Issuance Employment Inducement Grant [Member]
Stock Option Issuance - Employment Inducement Grant
Inducement Grant
Information pertaining to the Stock Option Issuance - Professional Service Fee Grant, as part of the Company's 2023 Omnibus Equity Incentive Plan.
Stock Option Issuance Professional Service Fee Grant [Member]
Professional Service Fee Grant
Vesting [Axis]
Vesting [Domain]
Vesting for share-based compensation awards designated as 25% in the 1st year and quarterly thereafter.
Share-Based Payment Arrangement, Vesting, 25 Percent in First Year and Quarterly Thereafter [Member]
25% 1st year and quarterly thereafter
Vesting for share-based compensation awards designated as fully vested upon grant.
Share-Based Payment Arrangement, Vesting, Fully Vested Upon Grant [Member]
Fully vested upon grant
Vesting for share-based compensation awards designated as monthly between 12 and 36 months.
Share-Based Payment Arrangement, Vesting, Monthly Between 12 and 36 Months [Member]
Monthly over periods ranging from 12-36 months
Vesting for share-based compensation awards designated as monthly over one year.
Share-Based Payment Arrangement, Vesting, Monthly Over One Year [Member]
Monthly over one year
Vesting for share-based compensation awards designated as monthly over three years.
Share-Based Payment Arrangement, Vesting, Monthly Over Three Years [Member]
Monthly over three years
Vesting for share-based compensation awards designated as quarterly over the first year.
Share-Based Payment Arrangement, Vesting, Quarterly Over the First Year [Member]
Quarterly over the first year
Exercise Price Range [Axis]
Exercise Price Range [Domain]
Exercise price range of $1.82 to $2.15.
Exercise Price, 1.82 to 2.15 [Member]
Exercise Price, $1.82 to $2.15
Exercise price range of $1.00.
Exercise Price, 1.00 [Member]
Exercise Price, $1.00
Exercise price range of $1.42.
Exercise Price, 1.42 [Member]
Exercise Price, $1.42
Exercise price range of $0.893.
Exercise Price, $0.893 [Member]
Exercise Price, $0.893
Exercise price range of $2.23.
Exercise Price, $2.23 [Member]
Exercise Price, $2.23
Exercise price range of $1.92 to $3.91.
Exercise Price, $1.92 to $3.91 [Member]
Exercise Price, $1.92 to $3.91
Exercise price range of $2.45.
Exercise Price, $2.45 [Member]
Exercise Price, $2.45
Exercise price range of $3.48.
Exercise Price, $3.48 [Member]
Exercise Price, $3.48
Exercise price range of $1.81.
Exercise Price, $1.81 [Member]
Exercise Price, $1.81
Exercise price range of $1.83.
Exercise Price, $1.83 [Member]
Exercise Price, $1.83
Grantee Status [Axis]
Grantee Status [Domain]
Share-Based Payment Arrangement, Employee [Member]
Employees
Share-Based Payment Arrangement, Nonemployee [Member]
Consultants
Director [Member]
Directors
Executive Officer [Member]
Executive Officers
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of options granted
Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Exercise price
Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Outstanding, end of period
Outstanding, beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Forfeited/expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding, end of period
Outstanding, beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Forfeited/expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Additional disclosures
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term
Weighted-average Remaining Contractual Term (in years), Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted-average Remaining Contractual Term (in years), Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term
Weighted-average Remaining Contractual Term (in years), Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate Intrinsic Value, Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Aggregate Intrinsic Value, Exercisable
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Exercise price range of $0.893 to $1.42.
Exercise Price, $0.893 to $1.42 [Member]
Exercise Price, $0.893 to $1.42
Exercise price range of $1.72 to $2.58.
Exercise Price, $1.72 to $2.58 [Member]
Exercise Price, $1.72 to $2.58
Exercise price range of $2.80 to $4.20.
Exercise Price, $2.80 to $4.20 [Member]
Exercise Price, $2.80 to $4.20
Exercise price range of $7.00 to $10.50.
Exercise Price, $7.00 to $10.50 [Member]
Exercise Price, $7.00 to $10.50
Exercise price range of $140.00 to $210.00.
Exercise Price, $140.00 to $210.00 [Member]
Exercise Price, $140.00 to $210.00
Exercise price range of $347.00 to $520.50.
Exercise Price, $347.00 to $520.50 [Member]
Exercise Price, $347.00 to $520.50
Exercise price range of $530.00 to $795.00.
Exercise Price, $530.00 to $795.00 [Member]
Exercise Price, $530.00 to $795.00
Exercise price range of $1,025.00 to $1,537.50.
Exercise Price, $1,025.00 to $1,537.50 [Member]
Exercise Price, $1,025.00 to $1,537.50
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-Based Compensation
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
Number Outstanding
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted-Average Remaining Contractual Term
Weighted-Average Remaining Life In Years
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
Weighted-Average Exercise Price
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Number Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Fair value of vested options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Options exercised, intrinsic value
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation cost
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Recognition period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Options, weighted-average grant date fair value
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Weighted-average risk free interest rate, Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Weighted-average risk free interest rate, Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Volatility, Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Volatility, Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected term (in years)
Share Price
Closing stock price
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Number of shares issued
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Unvested awards outstanding
Current Income Tax Expense (Benefit)
Current - Federal and state
Deferred Federal Income Tax Expense (Benefit)
Deferred - Federal
Deferred State and Local Income Tax Expense (Benefit)
Deferred - State
Deferred Income Tax Expense (Benefit)
Total
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Change in valuation allowance
Income Tax Paid, before Refund Received
Payments made for income taxes
Components of Deferred Tax Assets and Liabilities [Abstract]
Components of deferred tax assets and liabilities
Deferred Tax Assets, Operating Loss Carryforwards
Net operating loss
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Share-based compensation
Deferred Tax Assets, Other Tax Carryforwards
Capitalized research and development costs
Deferred Tax Assets, Tax Credit Carryforwards, Research
Research and development tax credit carryforward
Research and development tax credits
Deferred Tax Assets, Equity Method Investments
Investment in equity security
Deferred Tax Liabilities, Property, Plant and Equipment
Property, plant and equipment
Amount before allocation of valuation allowances of deferred tax asset, net of deferred tax liabilities, attributable to deductible temporary differences from intangible assets including goodwill.
Deferred Tax Assets (Liabilities), Goodwill and Intangible Assets
Intangible assets
Deferred Tax Assets, Tax Credit Carryforwards, Other
Operating and finance lease liabilities
Deferred Tax Liabilities, Leasing Arrangements
Operating and finance lease ROU assets
Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss
Accounts receivable
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities
Accrued expenses
Deferred Tax Assets, Charitable Contribution Carryforwards
Contribution carryforward
Deferred Tax Assets, Valuation Allowance
Valuation allowance
Deferred Tax Assets, Net
Total
Operating Loss Carryforwards [Table]
Legal Entity [Axis]
All Entities [Member]
Represents the information pertaining to BioPharma, Inc.
BioPharma, Inc. [Member]
BioPharma, Inc.
Operating Loss Carryforwards [Line Items]
Income Taxes
Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Federal net operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Federal net operating loss carryforwards, subject to expiration
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration
Federal net operating loss carryforwards, not subject to expiration
Deferred Tax Assets, Operating Loss Carryforwards, State and Local
State and local net operating loss carryforwards
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Income Taxes
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Statutory federal income tax rate
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
State taxes, net of federal benefit
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract]
Permanent differences:
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Incentive stock option
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount
Entertainment
Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to share-based payment arrangement expirations and forfeitures.
Effective Income Tax Rate Reconciliation, Share-Based Payment Arrangement, Expirations and Forfeitures, Amount
Expiration and forfeiture of stock options and restricted stock units
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Change in effective rate of state taxes
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
True ups and other
Tax Jurisdiction of Domicile [Extensible Enumeration]
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Percent
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Statutory federal income tax rate
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
State taxes, net of federal benefit
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract]
Permanent differences:
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent
Incentive stock option
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent
Entertainment
Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to share-based payment arrangement expirations and forfeitures.
Effective Income Tax Rate Reconciliation, Share-Based Payment Arrangement, Expirations and Forfeitures, Percent
Expiration and forfeiture of stock options and restricted stock units
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Change in effective rate of state taxes
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
True ups and other
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Change in valuation allowance
Effective Income Tax Rate Reconciliation, Percent
Effective income tax rate
Purchase Commitment, Excluding Long-Term Purchase Commitment [Table]
Purchase Commitment, Excluding Long-Term Commitment [Axis]
Purchase Commitment, Excluding Long-Term Commitment [Domain]
Purchase Commitment [Member]
CRO Agreements
Purchase Commitment, Excluding Long-Term Commitment [Line Items]
Commitments and Contingencies
Other Research and Development Expense
Costs related to clinical testing
Purchase Commitment, Remaining Minimum Amount Committed
Amount committed for additional costs
Defined Contribution Plan [Table]
Retirement Plan Name [Axis]
Retirement Plan Name [Domain]
Retirement Plan Name, Other [Member]
iBio 401(k) Plan
Defined Contribution Plan Disclosure [Line Items]
Employee 401(k) Plan
Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Employer matching contribution, percent of match
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Employer matching contribution, percent of employees gross pay
Defined Benefit Plan, Plan Assets, Contributions by Employer
Employer contribution expense
Subsequent Event [Table]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Subsequent Events
Information pertaining to the Stock Option Issuances - 2023 Plan, as part of the Company's 2023 Omnibus Equity Incentive Plan.
Stock Option Issuances 2023 Plan [Member]
Stock Option Issuances - 2023 Plan
Share-based payment arrangement vesting after one year.
Share-Based Payment Arrangement, Vesting After One Year [Member]
Vesting after one year
Share-based payment arrangement vesting in equal installments in years two through four.
Share-Based Payment Arrangement, Vesting in Equal Installments [Member]
Equal quarterly installments
Information pertaining to the AstralBio Amylin License agreement.
AstralBio Amylin License Agreement [Member]
AstralBio Amylin License Agreement
Subsequent Event [Line Items]
Subsequent Events
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Stock options vesting percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award
Term of awards